Since the Federal Trade Commission announced in 2022 that they would be inquiring into prescription drug middlemen, media coverage has amplified prescription drug pricing and the complex system in which it exists. For health care purchasers (employers and union trusts), there’s no better time than now to demand transparency and renegotiate contracts.
While millions of dollars are spent on prescription drugs in Washington state each year, the spending has been largely opaque. Join us for never-before-revealed insights into where the money is going.
Through this educational forum, attendees will learn:
- Learn about spread pricing in Washington, where it exists and its impact on patient costs.
- Strategies for plan sponsors to be better fiduciaries of your pharmacy benefits.
- Employer case studies to get to the right price.
Virtual attendance is optional. Select sessions will be made available by recording to all registrants. Breakfast and coffee will be provided to those who attend.
